Treatment Information

Back

Bladder Cancer treatment details. Chemotherapy.

University of Turin, Turin, Italy.

Survival: monthsCountry:Italy
Toxiciy Grade:3City/State/Province:Turin
Treatments:ChemotherapyHospital:University of Turin
Drugs:Journal:Link
Date:Jul 2013

Description:

Patients:
This phase 2 study involved 18 patients with carcinoma in situ (CIS) of the bladder. The median patient age was 75 years and 88.8% were male.

Treatment:
Patients received chemotherapy with gemcitabine.

Toxicities:
The most severe toxicities were grade 3 cystitis (bladder inflammation), pain, and leucopenia.

Results:
The median overall survival was 44 months.

Correspondence: Dr. Paolo Gontero; email: paolo.gontero@unito.it



Back